ICCC - IMMUCELL CORP /DE/
6.52
-0.010 -0.153%
Share volume: 9,481
Last Updated: 03-27-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$6.53
-0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-28-2025 | 05-14-2025 | 08-14-2025 | 11-13-2025 | |
| Cash flow financing | -366.543 K | -111.601 K | 3.212 M | 148.866 K | -403.647 K | -76.448 K | -337.689 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -18.394 K | 363.938 K | 2.484 M | -50.401 K | 841.139 K | 1.399 M | -2.112 M | |
| Net income | -437.868 K | -1.532 M | -701.690 K | 514.555 K | 1.447 M | 501.880 K | -139.748 K | |
| Depreciation | 662.477 K | 666.182 K | 670.346 K | 669.072 K | 671.191 K | 663.455 K | 674.312 K | |
| Changes in inventories | -662.278 K | 0.000 | 0.000 | 0.000 | 244.743 K | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -70.356 K | -106.241 K | -88.412 K | -196.216 K | -329.050 K | -125.927 K | -592.024 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 70.356 K | 106.241 K | 88.412 K | 196.216 K | 329.050 K | 155.159 K | 592.024 K | |
| Cash Change | -18.394 K | 363.938 K | 2.484 M | -50.401 K | 841.139 K | 1.399 M | -2.112 M |